Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment . Braz. J. Pharm. Sci. 2014;50(2):345-352. doi:10.1590/S1984-82502014000200014